Your session is about to expire
← Back to Search
START - Startle Adjuvant Rehabilitation Therapy for Stroke
Study Summary
This trial is testing a tool, START, which has the potential to directly target the causes leading to disparity of care for individuals with low socioeconomic status (SES). START is adjuvant, meaning it does not replace clinical practice but instead enhances current evidence-based treatments. The objective of this study is to determine if START can be used to enhance functionally relevant movement of the upper extremity in a group of 58 subjects.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What are the chief aims of this trial?
"This clinical trial aims to assess motor activity log retention and changes over a one month period through post-training evaluations. Secondary metrics include upper extremity Fugl-Meyer tests, Fugl Meyer retention assessments, and Modified Tardieu spasticity measurements."
What is the current extent of enrolment in this research?
"Affirmative. According to information hosted on clinicaltrials.gov, this trial is actively sourcing participants and was originally posted December 15th 2021. It requires 60 volunteers from one medical centre for participation."
Are new participants being welcomed into this experiment?
"Affirmative. Clinicaltrials.gov confirms that this clinical trial, initially posted on December 15th 2021, is actively recruiting patients at present. The team needs to onboard 60 individuals from a single research centre."
Who is qualified to partake in this exploration?
"This research project is seeking 60 individuals who have experienced a stroke in the 18-99 year old age bracket. In order to be eligible, applicants must provide informed consent, demonstrate suitable auditory thresholds according to their gender and age group, present moderate or severe deficits in upper extremity function (UEFM < 42/66), and possess at least 6 months worth of medical history surrounding their cerebrovascular accident . An estimated 30 percent participants will wear hearing aids; these devices should not disqualify them from consideration but instead be taken into account as part of data analysis."
Is this experimental research seeking participants over 20 years of age?
"The age range of participants for this study stretches from 18 years old to 99 years old."
Share this study with friends
Copy Link
Messenger